Publications
Academic article
- Christian Arvei Moen; Kristin Greve-Isdahl Mohn; Alexander Marks et al. (2026). Multifocal HPV16-positive squamous cell carcinomas in CTLA-4 haploinsufficiency: expanding the spectrum of virus-associated malignancies. (external link)
- Henrikke Nilsen Hovland; Rafal Isam Fatoohi Al-Adhami; Sarah Louise Ariansen et al. (2022). BRCA1 Norway: comparison of classification for BRCA1 germline variants detected in families with suspected hereditary breast and ovarian cancer between different laboratories. (external link)
- Nicola Bassi; Henrikke Hovland; Kashif Rasheed et al. (2023). Functional analyses of rare germline BRCA1 variants by transcriptional activation and homologous recombination repair assays. (external link)
- Henrikke Nilsen Hovland; Eunice Kabanyana Mchaina; Hildegunn Høberg Vetti et al. (2023). Functional Analyses of Rare Germline Missense BRCA1 Variants Located within and outside Protein Domains with Known Functions. (external link)
- Elisabet Ognedal Berge; Vidar Staalesen; Anne Hege Straume et al. (2010). Chk2 splice variants express a dominant-negative effect on the wild-type Chk2 kinase activity. (external link)
- Hildegunn Høberg Vetti; Elisabet Ognedal Berge; Adrien Buisson et al. (2020). The intronic BRCA1 c.5407-25T>A variant causing partly skipping of exon 23-a likely pathogenic variant with reduced penetrance?. (external link)
- Elisabet Ognedal Berge; Stian Knappskog; Stephanie Geisler et al. (2010). Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers. (external link)
- Eivind Berge; Kari Bente Foss; Else Charlotte Sandset et al. (2007). The Factor V Leiden, Prothrombin Gene 20210GA, Methylenetetrahydrofolate Reductase 677CT and Platelet Glycoprotein IIIa 1565TC Mutations in Patients With Acute Ischemic Stroke and Atrial Fibrillation. (external link)
- Isabel Spier; Xiaoyu Yin; Marcy Richardson et al. (2023). Gene-specific ACMG/AMP classification criteria for germline APC variants: Recommendations from the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel. (external link)
- Oleksii Nikolaienko; Hans Petter Eikesdal; Elisabet Ognedal Berge et al. (2023). Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development. (external link)
- Stian Knappskog; Elisabet Ognedal Berge; Ranjan Chrisanthar et al. (2015). Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo. (external link)
- Deepak Poduval; Elisabet Ognedal Berge; Zuzana Sichmanovà et al. (2020). Assessment of tumor suppressor promoter methylation in healthy individuals. (external link)
- Eivind Berge; Michel Abdelnoor; Per Hjalmar Nakstad et al. (2000). Heparin in acute embolic stroke trial (HAEST) - A double-blind, randomised study on the effect of low molecular weight heparin and aspirin in patients with acute ischaemic stroke and atrial fibrillation. (external link)
- Eivind Berge; Per Morten Sandset (2000). Heparin versus aspirin in ischaemic stroke. (external link)
- Per Morten Sandset; Eivind Berge (1996). Emboliske komplikasjoner ved atrieflimmer. (external link)
- Eivind Berge; Per Morten Sandset (1996). Hva er den beste behandlingen ved kardioembolisk hjerneslag?. (external link)
- Slot Karsten Mark Herman Bruins; Eivind Berge; Paul Dorman et al. (2008). Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies. (external link)
- Slot Karsten Mark Herman Bruins; Eivind Berge (2009). Thrombolytic Treatment for Stroke: Patient Preferences for Treatment, Information, and Involvement. (external link)
- Elisabet Ognedal Berge; Stian Knappskog; Johan R. Lillehaug et al. (2011). Alterations of the retinoblastoma gene in metastatic breast cancer. (external link)
- Elisabet Ognedal Berge; Johanna Huun; Johan R. Lillehaug et al. (2013). Functional characterisation of p53 mutants identified in breast cancers with suboptimal responses to anthracyclines or mitomycin. (external link)
- Ranjan Chrisanthar; Stian Knappskog; Erik Løkkevik et al. (2008). CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer. (external link)
- Xiaoyu Yin; Marcy Richardson; Andreas Laner et al. (2024). Large-scale application of ClinGen-InSiGHT APC-specific ACMG/AMP variant classification criteria leads to substantial reduction in VUS. (external link)
- David Russell; Lars Thomassen; Bent Indredavik et al. (2004). Pasienter med akutt hjerneinfarkt bør få trombolytisk behandling. (external link)
- Einar Elvbakken Birkeland; Christian Busch; Elisabet Ognedal Berge et al. (2013). Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma. (external link)
- Per Eystein Lønning; Elisabet Ognedal Berge; Merete Pauline Bjørnslett et al. (2018). White blood cell BRCA1 promoter methylation status and ovarian cancer risk. (external link)